Limits...
Effects of pharmacological treatments on hippocampal NCAM1 and ERK2 expression in epileptic rats with cognitive dysfunction

View Article: PubMed Central - PubMed

ABSTRACT

The present study aimed to investigate the effects of various pharmacological agents on the hippocampal expression of neural cell adhesion molecule 1 (NCAM1) and extracellular signal-regulated kinase 2 (ERK2) in epileptic rats with cognitive dysfunction. The experiments were conducted using 120 Wistar rats: 20 controls and 100 with pilocarpine-induced status epilepticus (SE). The SE rats were randomly assigned to 5 groups (n=20/group) that received daily treatments for 1 month with one of the following: (i) saline (no effect on epilepsy); (ii) carbamazepine (an anticonvulsant); (iii) oxcarbazepine (an anticonvulsant); (iv) aniracetam (a nootropic); or (v) donepezil (an acetylcholinesterase inhibitor). Spatial learning and memory were assessed using a Morris Water Maze (MWM). Hippocampal tissue was assessed for NCAM1 and ERK2 messenger RNA (mRNA) expression by reverse transcription polymerase chain reaction, and protein expression by immunochemistry. The results revealed that SE rats had significantly poorer MWM performances compared with controls (P<0.01). Performance in SE rats was improved with donepezil treatment (P<0.01), but declined with carbamazepine (P<0.01). Compared with controls, saline-treated SE rats exhibited increased hippocampal NCAM1 mRNA expression (P<0.01). Among SE rats, NCAM1 mRNA expression was highest in those treated with donepezil, followed by aniracetam-, saline-, oxcarbazepine- and carbamazepine-treated rats. Compared to controls, saline-treated SE rats exhibited decreased hippocampal ERK2 mRNA expression (P<0.01). Among SE rats, ERK2 mRNA expression was highest in those treated with donepezil, followed by aniracetam, saline, oxcarbazepine and carbamazepine. NCAM1 and ERK2 protein expression levels were parallel to those of the mRNA. In saline-treated SE rats, hippocampal ERK2 expression was decreased and NCAM1 expression was increased; thus, these two molecules may be involved in the impairment of spatial memory. Carbamazepine augmented this impairment, whereas donepezil was found to ameliorate the dysfunction associated with epilepsy. In conclusion, ERK2 and NCAM1 have significant roles in impairment of spatial memory in SE rats. Carbamazepine may increase this impairment, while donepezil may decrease this impairment.

No MeSH data available.


Related in: MedlinePlus

Relative hippocampal tissue expression of NCAM1 mRNA. Results for each group of rats are the NCAM1/β-actin mRNA ratios (n=5 rats/group). Agarose gel electrophoresis of (A) NCAM1 and (B) β-actin. (C) Relative hippocampal tissue expression of NCAM1 mRNA. *P<0.01 vs. epileptic group; #P<0.01 vs. control group. NCAM1, neural cell adhesion molecule 1; mRNA, messenger RNA.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4997984&req=5

f2-ol-0-0-4882: Relative hippocampal tissue expression of NCAM1 mRNA. Results for each group of rats are the NCAM1/β-actin mRNA ratios (n=5 rats/group). Agarose gel electrophoresis of (A) NCAM1 and (B) β-actin. (C) Relative hippocampal tissue expression of NCAM1 mRNA. *P<0.01 vs. epileptic group; #P<0.01 vs. control group. NCAM1, neural cell adhesion molecule 1; mRNA, messenger RNA.

Mentions: RT-PCR analysis of NCAM1 and β-actin mRNA expression was conducted in frozen hippocampal tissue from each group of rats. Figure 2 shows the mean relative NCAM1 expression (NCAM1/β-actin mRNA ratios) for each group (5 rats/group). The mean NCAM1 mRNA expression was significantly higher in the epileptic group (saline treatment) than in the normal control group (P<0.01). Thus, the SE model resulted in increased NCAM1 mRNA expression in the hippocampus.


Effects of pharmacological treatments on hippocampal NCAM1 and ERK2 expression in epileptic rats with cognitive dysfunction
Relative hippocampal tissue expression of NCAM1 mRNA. Results for each group of rats are the NCAM1/β-actin mRNA ratios (n=5 rats/group). Agarose gel electrophoresis of (A) NCAM1 and (B) β-actin. (C) Relative hippocampal tissue expression of NCAM1 mRNA. *P<0.01 vs. epileptic group; #P<0.01 vs. control group. NCAM1, neural cell adhesion molecule 1; mRNA, messenger RNA.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4997984&req=5

f2-ol-0-0-4882: Relative hippocampal tissue expression of NCAM1 mRNA. Results for each group of rats are the NCAM1/β-actin mRNA ratios (n=5 rats/group). Agarose gel electrophoresis of (A) NCAM1 and (B) β-actin. (C) Relative hippocampal tissue expression of NCAM1 mRNA. *P<0.01 vs. epileptic group; #P<0.01 vs. control group. NCAM1, neural cell adhesion molecule 1; mRNA, messenger RNA.
Mentions: RT-PCR analysis of NCAM1 and β-actin mRNA expression was conducted in frozen hippocampal tissue from each group of rats. Figure 2 shows the mean relative NCAM1 expression (NCAM1/β-actin mRNA ratios) for each group (5 rats/group). The mean NCAM1 mRNA expression was significantly higher in the epileptic group (saline treatment) than in the normal control group (P<0.01). Thus, the SE model resulted in increased NCAM1 mRNA expression in the hippocampus.

View Article: PubMed Central - PubMed

ABSTRACT

The present study aimed to investigate the effects of various pharmacological agents on the hippocampal expression of neural cell adhesion molecule 1 (NCAM1) and extracellular signal-regulated kinase 2 (ERK2) in epileptic rats with cognitive dysfunction. The experiments were conducted using 120 Wistar rats: 20 controls and 100 with pilocarpine-induced status epilepticus (SE). The SE rats were randomly assigned to 5 groups (n=20/group) that received daily treatments for 1 month with one of the following: (i) saline (no effect on epilepsy); (ii) carbamazepine (an anticonvulsant); (iii) oxcarbazepine (an anticonvulsant); (iv) aniracetam (a nootropic); or (v) donepezil (an acetylcholinesterase inhibitor). Spatial learning and memory were assessed using a Morris Water Maze (MWM). Hippocampal tissue was assessed for NCAM1 and ERK2 messenger RNA (mRNA) expression by reverse transcription polymerase chain reaction, and protein expression by immunochemistry. The results revealed that SE rats had significantly poorer MWM performances compared with controls (P&lt;0.01). Performance in SE rats was improved with donepezil treatment (P&lt;0.01), but declined with carbamazepine (P&lt;0.01). Compared with controls, saline-treated SE rats exhibited increased hippocampal NCAM1 mRNA expression (P&lt;0.01). Among SE rats, NCAM1 mRNA expression was highest in those treated with donepezil, followed by aniracetam-, saline-, oxcarbazepine- and carbamazepine-treated rats. Compared to controls, saline-treated SE rats exhibited decreased hippocampal ERK2 mRNA expression (P&lt;0.01). Among SE rats, ERK2 mRNA expression was highest in those treated with donepezil, followed by aniracetam, saline, oxcarbazepine and carbamazepine. NCAM1 and ERK2 protein expression levels were parallel to those of the mRNA. In saline-treated SE rats, hippocampal ERK2 expression was decreased and NCAM1 expression was increased; thus, these two molecules may be involved in the impairment of spatial memory. Carbamazepine augmented this impairment, whereas donepezil was found to ameliorate the dysfunction associated with epilepsy. In conclusion, ERK2 and NCAM1 have significant roles in impairment of spatial memory in SE rats. Carbamazepine may increase this impairment, while donepezil may decrease this impairment.

No MeSH data available.


Related in: MedlinePlus